ZA200709627B - Combination therapy - Google Patents
Combination therapyInfo
- Publication number
- ZA200709627B ZA200709627B ZA200709627A ZA200709627A ZA200709627B ZA 200709627 B ZA200709627 B ZA 200709627B ZA 200709627 A ZA200709627 A ZA 200709627A ZA 200709627 A ZA200709627 A ZA 200709627A ZA 200709627 B ZA200709627 B ZA 200709627B
- Authority
- ZA
- South Africa
- Prior art keywords
- combination therapy
- therapy
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68069205P | 2005-05-13 | 2005-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200709627B true ZA200709627B (en) | 2009-08-26 |
Family
ID=36997774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200709627A ZA200709627B (en) | 2005-05-13 | 2007-11-08 | Combination therapy |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060257400A1 (pt) |
EP (1) | EP1879588A2 (pt) |
CN (1) | CN101175495B (pt) |
BR (1) | BRPI0610806A2 (pt) |
CA (1) | CA2608473A1 (pt) |
MX (1) | MX2007013830A (pt) |
WO (1) | WO2006124689A2 (pt) |
ZA (1) | ZA200709627B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4994379B2 (ja) * | 2005-09-01 | 2012-08-08 | ブリストル−マイヤーズ スクイブ カンパニー | 血管内皮成長因子受容体−2モジュレーターに対する感受性を決定するためのバイオマーカーおよび方法 |
WO2007038648A1 (en) * | 2005-09-27 | 2007-04-05 | Bristol-Myers Squibb Company | Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
US7820421B2 (en) | 2007-02-08 | 2010-10-26 | Codexis, Inc. | Ketoreductases and uses thereof |
AR074830A1 (es) | 2008-12-19 | 2011-02-16 | Cephalon Inc | Pirrolotriazinas como inhibidores de alk y jak2 |
US20120045433A1 (en) * | 2010-08-17 | 2012-02-23 | Kapil Dhingra | Combination therapy |
US8709419B2 (en) | 2010-08-17 | 2014-04-29 | Hoffmann-La Roche, Inc. | Combination therapy |
US9295669B2 (en) | 2010-12-14 | 2016-03-29 | Hoffman La-Roche Inc. | Combination therapy for proliferative disorders |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030108545A1 (en) * | 1994-02-10 | 2003-06-12 | Patricia Rockwell | Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
US6889952B2 (en) * | 2001-11-02 | 2005-05-10 | Boone International, Inc. | Multi-position presentation easel |
TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
-
2006
- 2006-05-11 US US11/382,742 patent/US20060257400A1/en not_active Abandoned
- 2006-05-12 BR BRPI0610806-7A patent/BRPI0610806A2/pt not_active IP Right Cessation
- 2006-05-12 CA CA002608473A patent/CA2608473A1/en not_active Abandoned
- 2006-05-12 WO PCT/US2006/018579 patent/WO2006124689A2/en active Application Filing
- 2006-05-12 EP EP06759767A patent/EP1879588A2/en not_active Withdrawn
- 2006-05-12 MX MX2007013830A patent/MX2007013830A/es not_active Application Discontinuation
- 2006-05-12 CN CN200680016419XA patent/CN101175495B/zh not_active Expired - Fee Related
-
2007
- 2007-11-08 ZA ZA200709627A patent/ZA200709627B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101175495A (zh) | 2008-05-07 |
WO2006124689A2 (en) | 2006-11-23 |
CN101175495B (zh) | 2010-09-29 |
EP1879588A2 (en) | 2008-01-23 |
BRPI0610806A2 (pt) | 2010-07-27 |
CA2608473A1 (en) | 2006-11-23 |
MX2007013830A (es) | 2008-03-13 |
US20060257400A1 (en) | 2006-11-16 |
WO2006124689A3 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
GB0506147D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
GB0505437D0 (en) | Therapeutic agents | |
GB0504206D0 (en) | Combination therapy | |
GB0518819D0 (en) | Therapeutic agents | |
GB0518817D0 (en) | Therapeutic agents | |
GB0509052D0 (en) | Combination therapy | |
GB0417481D0 (en) | Combination therapy | |
GB0516661D0 (en) | Therapeutic agents | |
GB0514738D0 (en) | Therapeutic agents | |
GB0428180D0 (en) | Combination therapy | |
ZA200709627B (en) | Combination therapy | |
GB0507003D0 (en) | Therapeutic | |
GB0424339D0 (en) | Combination therapy | |
GB0518720D0 (en) | Therapeutic combination | |
GB0501655D0 (en) | Therapeutic use | |
GB0421436D0 (en) | Combination therapy | |
GB0421438D0 (en) | Combination therapy | |
GB0500659D0 (en) | Combination therapy | |
GB0500658D0 (en) | Combination therapy | |
GB0526132D0 (en) | Combination Therapy | |
GB0513778D0 (en) | Combination therapy | |
GB0514347D0 (en) | Combination therapy | |
GB0526121D0 (en) | Combination therapy |